Deeper genetic analysis with RNA sequencing provides better diagnostics and treatments for patients with everything from cancer to deadly virusesContinue reading→

Produced by Retro Report for The New York Times, A CHANGE OF HEART shows how  the modern-day SynCardia Total Artificial Heart has come full circle from its origins as a permanent heart to successfully pioneering use as a bridge to transplant to a new FDA clinical study for permanent use. Watch the documentary and hear what this life-saving and life-changing innovation means to the most important person…a patient.

Continue reading→

The University of Arizona announced the appointment of Dr. Roberta Diaz Brinton as the inaugural director of the University of Arizona Health Sciences Center for Innovation in Brain Science. Effective May 9, Dr. Brinton will join the UA from the University of Southern California where she has served as the R. Pete Vanderveen Chair in Therapeutic Discovery and Development. Continue reading→

The emm59 clone of group A Streptococcus is a deadly type of bacterial infection related to previous outbreak in CanadaContinue reading→

Barrow Neurological Institute at Phoenix Children’s Hospital Director, Dr. P.David Adelson reflects on how Dr. Allen Kaplan has made life better for children in our community for four decades.
Continue reading→

ASU spinout aims to shake up the health care status quo

Continue reading→

Partnership Tackles Lung Cancer, the No. 1 Cancer Killer Throughout the WorldContinue reading→

HB2310: biological products; prescription orders permits a pharmacist to substitute a biological product for a prescribed biological product if certain conditions are met, and outlines requirements relating to the substitution.  HB2310 received a 6 -0-1 vote  and Do Pass as Amended  recommendation from the Senate Health and Human Services Committee on March 9, 2016.  Read the Senate Fact Sheet.  The next step in the process is review by the Senate Rules Committee.
Continue reading→

HealthTell™, has raised $26M in new investment according to its latest filing with the SEC  and expanded its Clinical Advisory Board with the additions of John Galgiani, M.D., and Chaim Putterman, M.D., as Clinical Advisors.Continue reading→

On March 10, 2016, the Pharmaceutical Research and Manufacturers of America (PhRMA) 2016 Annual Meeting, PhRMA president and CEO Stephen J. Ubl announced the association’s policy solutions for delivering innovative treatments to patients.Continue reading→